Johnson Midwest Financial’s Co-Diagnostics CODX Stock Holding History

Johnson Midwest Financial’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$106	Hold	3	–	–	﹤0.01%	373
2023 Q2	$111	Hold	3	–	–	﹤0.01%	366
2023 Q1	$148	Hold	3	–	–	﹤0.01%	379
2022 Q4	$0	Hold	3	–	–	﹤0.01%	376
2022 Q3	$0	Hold	3	–	–	﹤0.01%	330
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	288
2022 Q1	$1K	Hold	3	–	–	﹤0.01%	264
2021 Q4	$1K	Hold	3	–	–	﹤0.01%	279
2021 Q3	$1K	Hold	3	–	–	﹤0.01%	290
2021 Q2	$1K	Hold	3	–	–	﹤0.01%	275
2021 Q1	$1K	Hold	3	–	–	﹤0.01%	256
2020 Q4	$1K	Buy	+3	New	+$1.11K	﹤0.01%	257

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Johnson Midwest Financial's CODX Position: Q3 2023 in Review

Johnson Midwest Financial held its Co-Diagnostics (CODX) position steady in Q3 2023 at 3 shares worth $106. The position accounts for ﹤0.01% of the portfolio, ranked #373.

Johnson Midwest Financial first reported a position in CODX in Q4 2020 and has held it in 12 quarters since. The position peaked at $1K in Q2 2022. 43 funds tracked by Wall St. Rank hold CODX as of Q3 2023.

Johnson Midwest Financial held 3 shares of Co-Diagnostics worth $106 as of Q3 2023.
Johnson Midwest Financial left its Co-Diagnostics share count unchanged in Q3 2023.
Co-Diagnostics made up ﹤0.01% of Johnson Midwest Financial's portfolio in Q3 2023, its #373 holding.
Johnson Midwest Financial first reported a position in Co-Diagnostics in Q4 2020 and has held it in 12 quarters since.
Johnson Midwest Financial's Co-Diagnostics position peaked at $1K in Q2 2022.
43 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.